Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Transferases
Reexamination Certificate
2006-08-01
2006-08-01
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Transferases
C435S193000, C435S252300, C435S320100, C536S023200
Reexamination Certificate
active
07083783
ABSTRACT:
A method for increasing outflow facility and reducing intraocular pressure from an eye of a subject having glaucoma includes the step of administering to the eye an amount of an ADP ribosyltransferase protein effective to reduce intraocular pressure and increase outflow facility.
REFERENCES:
patent: 5798380 (1998-08-01), Kaufman et al.
patent: 6110912 (2000-08-01), Kaufman et al.
patent: 6555107 (2003-04-01), Poeschla et al.
patent: 6586425 (2003-07-01), Kaufman et al.
Andrawiss M., et al., “Adenovirus-mediated gene transfer in canine eyes: a preclinical study for gene therapy of human uveal melanoma,” J. Gene. Med., 3:228-239 (2001).
Borras, T., et al., “Ocular adenovirus gene transfer in efficiency and inflammatory response,” Invest Ophthalmol. Vis. Sci., 37:1282-1293 (1996).
Borras, T., et al., “Gene transfer to the human trabecular meshwork by anterior segment perfusion,” Invest Ophthalmol Vis Sci., 39:1503-1507 (1998).
Borras, T., et al., “Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma,” Gene ber 6:515-524 (1999).
Borras, T., et al., “Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo,” J. Gene. Med., 3:437-449 (2001).
Borras, T., et al., “Gene Therapy for Glaucoma: Treating a Multifaceted, Chronic Disease,” Invest. Ophthalmol. Vis. Sci., 43:2513 (2002).
Budenz, D., et al., “In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells,” Invest. Ophthalmol. Vis. Sci., 36:2211-2215 (1995).
Hauswirth, W. & Beaufrere, L., “Ocular Gene Therapy: Quo Vadis?,” Invest. Ophthalmol. Vis. Sci., 41:2821-2826 (2000).
Kee, C., et al., “Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo,” Ophthalmol. Vis. Sci., 42:2856-2860 (2001).
Loewen, N., et al., “Preservation of Aqueous Outflow Facility after Second-Generation FIV Vector-Mediated Expression of Marker Genes in Anterior Segments of Human Eyes,” Invest. Ophthalmol. Vis. Sci., 43:3686-3690 (2002).
Loewen, N., et al., “Long-Term, Targeted Genetic Modification of the Aqueous Humor Outflow Tract Coupled with Noninvasive Imaging of Gene Expression In Vivo,” Invest. Ophthalmol. Vis. Sci 45:3091-3098 (2004).
Loewen N., et al., “Long-term retinal transgene expression with FIV versus adenoviral vectors,” Mol Vis., 10:272-280 (2004).
Nakamura, Y., et al., “Signaling mechanism of TGF-beta 1-induced collagen contraction mediated by bovine trabecular meshworks cells ,” Invest. Ophthalmol. Vis. Sci 43:3465-3472 (2002).
Popoff, M., et al., “Characterization of the C3 gene of Clostridium botulinum types C and D and its expression inEscherichia coli,” Infect. Immun., 59:3673-3679 (1991).
Honjo Megumi, et al., “Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility,” IOVS, vol. 42, No. 1, pp. 137-144 (Jan. 2001).
Deng P., et al., “Regulation of trabecular meshwork myosin light chain phosphorylation by Rho/Rho kinase pathway and its influence on aqueous humor outflow facility,” Database Biosis Online Biosciences Information Service Philadelphia PA, US (2003).
Wilde C., et al., “the Rho-ADP-ribosylating C3 exoenzyme from Clostridium bofulinum and related C3-like transferases,” Toxicon, Elmsford, NY, US, vol. 39, No. 11, pp. 1647-1660 (Nov. 2001).
Rao V., et al., “Rho GTPase inactivation impairs lens growth and integrity,” Laboratory Investigation; a Journal of Technical Methods and Pathology, vol. 82, No. 2, pp. 231-239 (Feb. 2002).
EP 1 034 793 A1 (Senju Pharmaceutical Co., Ltd.; Mitsubishi Pharma Corporation) p. 2, paragraph 4-9 (Sep. 13, 2000).
Liu X., et al., “Exoenzyme C3 transferase gene transfer to cultured human trabecular meshwork cells and ciliary muscle cells-towards glaucoma gene therapy,” Invest. Ophthalmol. Vis. Scie. Online, vol. 45 (2004).
Kaufman Paul L.
Liu Xuyang
Quarles & Brady LLP
Saidha Tekchand
Wisconsin Alumni Research Foundation
LandOfFree
Method for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3700687